CTRI/2018/05/013864已完成2 期
Clinical trial on Hyperlipidemia (Kasrat-e-Shahmuddam) with UNIM-763
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Reduction of Serum Cholesterol and Serum Triglycerides
研究概览
简要总结
Hyperlipidemia is an increase in either plasma cholesterol, plasma triglycerides. Epidemiological study indicate that cholesterol level above 250 mg/100 ml. significantly raise the risk for coronary heart disease *CHD).
Recent clinical trials show that treatment of hyperlipidemia with allopathic drugs reduces the risk for coronary heart disease. Some of the Unani drugs have the capacity to regulate lipid abnormalities. If atherosclerosis can be prevented by regulating the abnormal lipid metabolism, we may be able to manage successfully one aspect of coronary heart disease.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Participant and Investigator Blinded
入排标准
- 年龄范围
- 30.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Serum cholesterol: > 200 mg/dl 2.Serum Triglycerides: >150 mg / dl 3.LDL: > 115 mg/ dl 4.HDL: > 40 5.Patient should be willing to cooperate the study protocol 6.Patient should be give written informed consent 7.Patient should not have any other disease.
排除标准
- •1.Un control diabetes mellitus 2.History of IHD 3.History of drug/alcohol abuse 4.Non cooperative patients.
结局指标
主要结局
Reduction of Serum Cholesterol and Serum Triglycerides
时间窗: Baseline, 1st month, 2nd month, 3rd month
次要结局
- Safety with Pathological and biochemical tests(Before and after treatment)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Treatment of Hyperlipedemia with Unani formulatioCTRI/2018/05/013864Central Council for Research in Unani Medicine60
尚未招募
2 期
Clinical effectiveness of Unani drugs in comparison to conventional drug in the treatment of dyslipidaemia (abnormal amount of fat in the blood)CTRI/2019/05/019066Central Research Institute of Unani Medicine60
招募中
1 期
A Phase 1 study to evaluate safety and tolerability of Anti-PCSK9 Product (ZRC-3306) administered subcutaneously in healthy adult human subjectsCTRI/2024/01/062126Zydus Lifesciences Ltd Formerly Cadila Healthcare Limited60
已完成
不适用
Venthamarai chooranam & yoga for hyperlipidemiaCTRI/2023/06/05350430
已完成
3 期
Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering DrugsHIV InfectionNCT01543035Calmy Alexandra34